Skip to content
← Non-Small Cell Lung Cancer

HEALTH PROFESSIONAL · SOURCE READING

Treatment of brain metastases

Source: Non-Small Cell Lung Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: May 15, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

Context: Treatment of Newly Diagnosed Stage IV, Relapsed, and Recurrent NSCLC / Treatment Options for Newly Diagnosed Stage IV, Relapsed, and Recurrent NSCLC (First-Line Therapy) / Local therapies and special considerations

Patients who present with a solitary cerebral metastasis after resection of a primary NSCLC lesion and who have no evidence of extracranial tumor can achieve prolonged disease-free survival with surgical excision of the brain metastasis and postoperative whole-brain radiation therapy.[114,115] Unresectable brain metastases in this setting may be treated with stereotactic radiosurgery.[116]

Source links and citations

Approximately 50% of patients treated with resection and postoperative radiation therapy will develop recurrence in the brain; some of these patients will be suitable for additional treatment.[117] In those selected patients with good performance status and without progressive metastases outside of the brain, treatment options include reoperation or stereotactic radiation surgery.[116,117] For most patients, additional radiation therapy can be considered; however, the palliative benefit of this treatment is limited.[118][Level of evidence C2]

Source links and citations

Publication references

Read the original reference and check its publication notices.

Preserved source evidence · Not medical advice